138 related articles for article (PubMed ID: 11964431)
1. Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users.
Bouhnik AD; Moatti JP; Vlahov D; Gallais H; Dellamonica P; Obadia Y;
J Epidemiol Community Health; 2002 May; 56(5):349-53. PubMed ID: 11964431
[TBL] [Abstract][Full Text] [Related]
2. Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up.
Vincent E; Bouhnik AD; Carrieri MP; Rey D; Dujardin P; Granier F; Fuzibet JG; Obadia Y; Moatti JP; Spire B;
AIDS; 2004 Jun; 18(9):1321-5. PubMed ID: 15362665
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
[TBL] [Abstract][Full Text] [Related]
4. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.
Carrieri MP; Moatti JP; Vlahov D; Obadia Y; Reynaud-Maurupt C; Chesney M
J Epidemiol Community Health; 1999 Jan; 53(1):4-8. PubMed ID: 10326045
[TBL] [Abstract][Full Text] [Related]
5. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
6. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users.
Vlahov D; Safaien M; Lai S; Strathdee SA; Johnson L; Sterling T; Celentano DD
AIDS; 2001 Nov; 15(17):2311-6. PubMed ID: 11698705
[TBL] [Abstract][Full Text] [Related]
7. Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.
Fu TC; Westergaard RP; Lau B; Celentano DD; Vlahov D; Mehta SH; Kirk GD
AIDS; 2012 Nov; 26(18):2383-91. PubMed ID: 23079804
[TBL] [Abstract][Full Text] [Related]
8. Severe food insecurity is associated with elevated unprotected sex among HIV-seropositive injection drug users independent of HAART use.
Shannon K; Kerr T; Milloy MJ; Anema A; Zhang R; Montaner JS; Wood E
AIDS; 2011 Oct; 25(16):2037-42. PubMed ID: 21811140
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
10. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users.
Carrieri MP; Chesney MA; Spire B; Loundou A; Sobel A; Lepeu G; Moatti JP;
Int J Behav Med; 2003; 10(1):1-14. PubMed ID: 12581944
[TBL] [Abstract][Full Text] [Related]
11. Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection?
Stephenson JM; Imrie J; Davis MM; Mercer C; Black S; Copas AJ; Hart GJ; Davidson OR; Williams IG
Sex Transm Infect; 2003 Feb; 79(1):7-10. PubMed ID: 12576605
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
Wood E; Hogg RS; Lima VD; Kerr T; Yip B; Marshall BD; Montaner JS
JAMA; 2008 Aug; 300(5):550-4. PubMed ID: 18677027
[TBL] [Abstract][Full Text] [Related]
13. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.
Celentano DD; Galai N; Sethi AK; Shah NG; Strathdee SA; Vlahov D; Gallant JE
AIDS; 2001 Sep; 15(13):1707-15. PubMed ID: 11546947
[TBL] [Abstract][Full Text] [Related]
14. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
[TBL] [Abstract][Full Text] [Related]
15. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
Tun W; Gange SJ; Vlahov D; Strathdee SA; Celentano DD
Clin Infect Dis; 2004 Apr; 38(8):1167-74. PubMed ID: 15095224
[TBL] [Abstract][Full Text] [Related]
16. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men.
Ostrow DE; Fox KJ; Chmiel JS; Silvestre A; Visscher BR; Vanable PA; Jacobson LP; Strathdee SA
AIDS; 2002 Mar; 16(5):775-80. PubMed ID: 11964534
[TBL] [Abstract][Full Text] [Related]
17. Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group.
Carrieri MP; Vlahov D; Dellamonica P; Gallais H; Lepeu G; Spire B; Obadia Y
Drug Alcohol Depend; 2000 Jul; 60(1):51-4. PubMed ID: 10821989
[TBL] [Abstract][Full Text] [Related]
18. Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response.
Fardet L; Mary-Krause M; Heard I; Partisani M; Costagliola D;
HIV Med; 2006 Nov; 7(8):520-9. PubMed ID: 17105511
[TBL] [Abstract][Full Text] [Related]
19. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
[TBL] [Abstract][Full Text] [Related]
20. Injecting drug use in pregnant HIV-infected women in Europe.
Thorne C; Newell ML
Med Wieku Rozwoj; 2006; 10(4):1005-16. PubMed ID: 17426368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
